← Leaderboards
Larry K Keefer
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Nitric Oxide”
- Solomon H Snyder · Johns Hopkins University$33,003,131
- Jay Louis Zweier · Ohio State University$27,671,715
- Stuart A Lipton · Burnham Institute For Medical Research$26,301,120
- Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru$24,661,240
- Jonathan S. Stamler · Case Western Reserve University$24,571,968
- William C. Sessa · Yale University$21,022,028
Research focus
Nitric OxideDiazeniumdiolateDesignProgramsCollaborationsLeadAntineoplastic AgentsProdrugsCellsBasic ScienceCatalysisBaseLeukemiaKidneyLung NeoplasmsNitroxylGlutathioneHalf-LifeInterestClinical ApplicationDna RepairBiomedical ResearchAnionsDissociation
Grant awards (23)
Diazeniumdiolates as Broad-Spectrum Anticancer Agents$532,298
ZIA · FY2015 · CA · contact PI
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies$532,298
ZIA · FY2015 · CA · contact PI
Diazeniumdiolates as Broad-Spectrum Anticancer Agents$757,433
ZIA · FY2014 · CA · contact PI
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies$757,433
ZIA · FY2014 · CA · contact PI
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies$730,343
ZIA · FY2013 · CA · contact PI
Diazeniumdiolates as Broad-Spectrum Anticancer Agents$730,343
ZIA · FY2013 · CA · contact PI
Diazeniumdiolates as Broad-Spectrum Anticancer Agents$909,984
ZIA · FY2012 · CA · contact PI
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies$909,984
ZIA · FY2012 · CA · contact PI
Diazeniumdiolates as Broad-Spectrum Anticancer Agents$919,966
ZIA · FY2011 · CA · contact PI
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies$919,966
ZIA · FY2011 · CA · contact PI
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies$789,453
ZIA · FY2010 · CA · contact PI
Diazeniumdiolates as Broad-Spectrum Anticancer Agents$789,453
ZIA · FY2010 · CA · contact PI
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies$878,706
ZIA · FY2009 · CA · contact PI
Diazeniumdiolates as Broad-Spectrum Anticancer Agents$585,804
ZIA · FY2009 · CA · contact PI
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies$1,633,328
Z01 · FY2008 · CA · contact PI
Diazeniumdiolate Chemistry as a Platform for Designing Nitric Oxide-Based Therap$1,253,894
Z01 · FY2007 · CA · contact PI
Diazeniumdiolate Chemistry as a Platform for Designing N$0
Z01 · FY2006 · BC · contact PI
Diazeniumdiolate Chemistry as a Platform for Designing N$0
Z01 · FY2005 · BC
Diazeniumdiolate Chemistry as a Platform for Designing N$0
Z01 · FY2004 · BC
Diazeniumdiolate Chemistry as a Platform for Designing N$0
Z01 · FY2003 · BC
Diazeniumdiolate Chemistry as a Platform for Designing N$0
Z01 · FY2002 · BC
Diazeniumdiolate Chemistry for Designing NO Based Therap$0
Z01 · FY2001 · BC
Chemistry and Biology of Nitric Oxide$0
Z01 · FY2000 · BC